APOA1 and ovarian cancer: In the clinic, the diagnostic value of APOA-I as a potential tumor biomarker was also reported in multiple malignancies, such as breast cancer, lung cancer, ovarian cancer, bladder cancer and cholangiocarcinoma [40].